| PERIOD ENDING | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | 28-Sep-08 | | Total Revenue | 107,007 | 105,693 | 130,594 | 134,673 | | Cost of Revenue | 61,838 | 72,981 | 70,161 | 71,586 | | | Gross Profit | 45,169 | 32,712 | 60,433 | 63,087 | | | Operating Expenses | | Research Development | 10,032 | 10,209 | 10,767 | 11,546 | | Selling General and Administrative | 25,748 | 31,218 | 30,605 | 26,231 | | Non Recurring | 1,461 | 4,528 | 1,905 | 279 | | Others | 4,154 | 3,562 | 3,244 | 3,098 | | | | Total Operating Expenses | 41,395 | 49,517 | 46,521 | 41,154 | | | | Operating Income or Loss | 3,774 | (16,805) | 13,912 | 21,933 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,032 | 452 | 729 | 682 | | Earnings Before Interest And Taxes | 4,806 | (16,353) | 14,641 | 22,615 | | Interest Expense | 63 | 182 | 56 | 64 | | Income Before Tax | 4,743 | (16,535) | 14,585 | 22,551 | | Income Tax Expense | (3,100) | 77 | 1,377 | 5,262 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 7,843 | (16,612) | 13,208 | 17,289 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 7,843 | (16,612) | 13,208 | 17,289 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $7,843 | ($16,612) | $13,208 | $17,289 |
|
0.24% Nasdaq 
Income Statement
